Dr. Daniel Cameron

Major stories for 2014 on Lyme disease and other tick-borne diseases. Covering newly discovered tick-borne pathogens, the spread of existing tick-borne diseases into new geographic regions, an increasing focus on co-infections and legislative and educational efforts to deal with the growing epidemic of Lyme disease.

The Senate’s unanimous passing of Bill C-442, An Act to Create a Federal Framework on Lyme disease, provides hope and promise for both current and future Lyme disease patients. The following article, entitled “No Coordination of Care in Canadian Health Care,” published recently in The Medicine Hat News, describes the struggles that are all-too typical for so many Canadians

While many of the points addressed in the Bill have been agreed upon by all stakeholders at the meeting, certain wording within the bill has created concern for infectious disease specialists, who argue that it suggests support for ‘pseudo-science’ treatment guidelines, while dismissing current evidence-based guidelines put forth by the Infectious Disease Society of America

While the journal authors acknowledge that field studies indicate confirmed endemic areas or potential, future risk areas for ticks has grown from 1 region in 1997 to 13 regions in 2006, the authors minimize the growing concern of tick-borne illness in Canada. They point to the minor number of reported cases. In 2013, 500 cases were reported in Canada.  However, the number of reported Lyme disease

Guest Blog By Jennifer Bybel Lown,  Nurse Practitioner Dr. Daniel Cameron & Associates While Lyme disease isn’t necessarily rare, it is a less understood disease, surrounded by conflicting information. And, one in which, all too frequently, family members seem to be more knowledgeable than medical professionals. We recently treated a patient who had been sick

If the FDA gets its way, physicians would only have access to diagnostic tests for tick borne diseases that are FDA approved.  This would eliminate “specialty labs,” and severely restrict a clinicians ability to diagnose Lyme disease, as well as other tick-borne co-infections. This is a dangerous move in a period when we’re seeing an